BUSINESS
Biocon Rises After Subsidiary Gets USFDA Tentative Nod for Rifaximin Tablets 550 mg
Mumbai, October 7 (Udaipur Kiran): Shares of Biocon edged higher after its wholly owned subsidiary Biocon Pharma, in partnership with Carnegie Pharmaceuticals LLC, received tentative approval from the…
